Abstract
IntroductionClinical trials show that calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) are effective preventative treatments for chronic migraine. Their efficacy over longer time periods and in cohorts originally excluded from...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have